MK-0869-071

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0869-071, covering 2017-05-05 to 2017-05-05. Get the full timeline:

Most recent: Clinical Trial Update: An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) [Phase 4]